| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018981A1 Implants comprising combinations of allogeneic cells for use in cancer treatment |
| 04/22/1999 | WO1999018980A1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
| 04/22/1999 | WO1999018799A1 Treatment of neoplasms with viruses |
| 04/22/1999 | WO1999018798A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/22/1999 | WO1999006561A3 Chemokine receptor ccr8 dna and uses thereof |
| 04/22/1999 | WO1999004811A9 Artificial system for the production of infectious human papillomavirus |
| 04/22/1999 | WO1999004011A3 Hiv-1 group o antigens and uses thereof |
| 04/22/1999 | WO1999003501A9 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide |
| 04/22/1999 | WO1999002565A3 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 04/22/1999 | WO1999001556A3 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 04/22/1999 | WO1998048837A9 Polyalkylene oxide-modified single chain polypeptides |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | WO1998044788A9 Animal model for evaluation of vaccines |
| 04/22/1999 | WO1998044143A9 Polymer-modified viruses |
| 04/22/1999 | DE19746173A1 Tumor vaccine based on tumor antigens comprises a slow-release system of gamma-interferon (IFN-gamma |
| 04/22/1999 | DE19745443A1 Diagnostic polyclonal antiserum specific for prion protein |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2308009A1 Novel npy family member |
| 04/22/1999 | CA2307328A1 Cell division regulators |
| 04/22/1999 | CA2307208A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/22/1999 | CA2306476A1 Enterococcus antigens and vaccines |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306451A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305643A1 Murine model for human carcinoma |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0909819A1 Streptococcus pneumoniae Isoleucyl tRNA synthetase (Iles)[6.1.1.5.] |
| 04/21/1999 | EP0909818A1 Valyl tRNA synthetase (EC 6.1.1.9) from Streptococcus pneumoniae |
| 04/21/1999 | EP0909816A1 Anti-fas antibodies |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909323A1 Helicobacter pylori bacterioferritin |
| 04/21/1999 | EP0909316A1 Glial cell line-derived neurotrophic factor receptor |
| 04/21/1999 | EP0909277A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
| 04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | EP0909179A2 T-cell dependent vaccine and the cell surface receptor cd28 |
| 04/21/1999 | EP0664834B1 Recombinant humanized anti-cytomegalovirus antibodies |
| 04/21/1999 | EP0644947B1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 04/21/1999 | EP0640131B1 Genetically engineered antibodies |
| 04/21/1999 | CN1214695A ErdB3 antibodies |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/21/1999 | CN1214367A Monoclonal antibody for human anti-hantaan virus glycoprotein neutralization gene engineering |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895811 Artificial positive controls derived from bifunctional conjugates |
| 04/20/1999 | US5895756 Non-antibiotic system for selection of recombinant mycobacteria |
| 04/20/1999 | US5895750 Immunoassay for the detection of ligands |
| 04/20/1999 | US5895746 Immunoassay for detecting label bound to intact trimeric alpha1-homotrimeric peptide isolated without use of proteolytic enzymes |
| 04/20/1999 | US5895655 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens |
| 04/20/1999 | US5895654 Streptococcus equi vaccine |
| 04/20/1999 | US5895653 Sterile iron(iii) hydroxide; water in oil emulsion; antigens, immunogens; adsorbed interleukin, cytokine and/or interferon |
| 04/20/1999 | US5895651 Recombinant dengue virus envelope protein/maltose-binding protein antigens and subunit vaccine compositions containing said antigens |
| 04/20/1999 | US5895649 Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists |
| 04/20/1999 | CA2133649C Oral infection of insect larvae with pre-occluded baculovirus particles |
| 04/20/1999 | CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents |
| 04/20/1999 | CA1340506C Production of gonorrheal pi proteins and vaccines |
| 04/15/1999 | WO1999018235A1 Process for detecting, extracting or removing human or mammalian cells with a disturbed cellular cycle regulation or unlimited proliferation or tumour-forming ability |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018225A1 Expression of cholera toxin b subunit in transgenic plants and efficacy thereof in oral vaccines |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018220A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | WO1999018216A2 Chimeric vaccine against tick-borne encephalitis virus |
| 04/15/1999 | WO1999018215A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018210A2 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer |
| 04/15/1999 | WO1999018206A2 Human cancer antigen ny eso-1/cag-3 and gene encoding same |
| 04/15/1999 | WO1999018194A1 GENE DELETED RECOMBINANT FeLV PROVIRAL DNA FOR PRODUCTION OF VACCINES AGAINST FeLV |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018142A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 04/15/1999 | WO1999018129A1 Soluble single-chain t-cell receptor proteins |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018121A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999018115A1 Polynucleotide sequences from candida albicans encoding polypeptides associated with filamentous growth |
| 04/15/1999 | WO1999017802A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | WO1999017801A2 Materials and methods relating to the stimulation of cells |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017796A2 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | WO1999017792A1 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999017791A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | WO1999017789A1 Peptide compositions for the treatment and prevention of hiv infection |
| 04/15/1999 | WO1999017783A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017709A2 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999017610A1 Protein delivery by secretory gland expression |
| 04/15/1999 | WO1999009054A3 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 04/15/1999 | WO1999008708A3 Method and food product for increasing muscle protein and reducing fat in animals |
| 04/15/1999 | WO1999007854A3 Serine/threonine kinase, and uses related thereto |
| 04/15/1999 | WO1999005502A3 Modulation of multicellular aggregates by solid stress |
| 04/15/1999 | WO1999005313A3 Method for typing of minor histocompatibility antigen ha-1 |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |